ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

10,540Medicare Part D Prescriptions Filled, Including Refills
$802K Total Retail Price of All Prescriptions
708 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
OMEPRAZOLE 351 284
LEVOTHYROXINE SODIUM 330 297
ATENOLOL 323 284
AMLODIPINE BESYLATE 321 302
SIMVASTATIN 319 251
FUROSEMIDE 294 201
LISINOPRIL 290 253
HYDROCODONE-ACETAMINOPHEN 221 171 S3
ATORVASTATIN CALCIUM 216 177
PRAVASTATIN SODIUM 196 171
WARFARIN SODIUM 195 171
LOSARTAN POTASSIUM 193 169
METOPROLOL TARTRATE 187 145
CRESTOR 174 136
METFORMIN HCL 172 126
SERTRALINE HCL 168 124
HYDROCHLOROTHIAZIDE 165 151
ZOLPIDEM TARTRATE 160 82
CIPROFLOXACIN HCL 148 138
KLOR-CON M20 127 113
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 100
CITALOPRAM HBR 115 88
ALENDRONATE SODIUM 113 101
LIPITOR 107 85
ALLOPURINOL 105 101
GABAPENTIN 102 97
LOVASTATIN 101 88
PREDNISONE 99 93
TAMSULOSIN HCL 98 95
AZITHROMYCIN 84 67
RANITIDINE HCL 80 38
SYNTHROID 80 58
GLIMEPIRIDE 76 48
LEVOFLOXACIN 74 57
NEXIUM 73 57
POLYETHYLENE GLYCOL 3350 73 63
LOSARTAN-HYDROCHLOROTHIAZIDE 71 66
DIOVAN 70 65
DONEPEZIL HCL 69 69
DILTIAZEM 24HR ER 68 57
AMOXICILLIN 65 52
ONDANSETRON HCL 65 47
ADVAIR DISKUS 63 56
OXYCODONE-ACETAMINOPHEN 60 27 S2
FLUTICASONE PROPIONATE 58 47
LORAZEPAM 57 37
TRAMADOL HCL 57 49
CYMBALTA 56 33
CLINDAMYCIN PHOSPHATE 55 51
METHYLPREDNISOLONE 54 41
PROAIR HFA 53 33
ALPRAZOLAM 52 34
CLOTRIMAZOLE-BETAMETHASONE 52 39
TRAZODONE HCL 51 32
METOPROLOL SUCCINATE 50 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.